XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.4
ACQUISITIONS AND DISPOSITIONS (Details Narrative) - USD ($)
9 Months Ended
Jan. 08, 2024
Sep. 27, 2023
Jul. 31, 2023
Jul. 31, 2023
Sep. 30, 2023
Aug. 22, 2023
Feb. 04, 2023
Sep. 30, 2021
Notes payable         $ 5,255,000      
Debt Instrument, Face Amount               $ 630,000
Gain loss on disposal of assets         $ 3,209,776      
Promissory Note [Member]                
Debt Instrument, Face Amount           $ 125,000    
Promissory Note [Member] | Community Speciality Pharmacy LLC [Member]                
Debt Instrument, Face Amount           $ 100,000    
Alliance Pharma Solutions LLC [Member]                
Ownership percentage           100.00%    
SOSRx, LLC [Member]                
Notes payable             $ 500,000  
Accounts payable             $ 15,000  
Asset Purchase Agreement [Member]                
Asset acquisition consideration transferred   $ 3,150,000            
Series B Preferred Stock [Member]                
Stock issued     100          
Series B Preferred Stock [Member] | Merger Agreement [Member]                
Stock issued during period shares other 136,441     136,441        
Stock issued and outstanding percentage       19.99%        
Stock issued during period shares conversion of units 15,759     306,855        
Stock issued during period shares conversion of units 0.00001              
Series B Preferred Stock [Member] | Merger Agreement [Member] | Superlatus, Inc. [Member]                
Business acquisition percentage of voting interests acquired     100.00% 100.00%        
Business acquisition share price     $ 7.30 $ 7.30        
Stock issued and outstanding percentage 19.99%     19.99%        
Business combination step acquisition equity interest in acquiree fair value $ 12,500,089     $ 225,000,169        
Series B Preferred Stock [Member] | Amended Meger Agreement [Member] | Subsequent Event [Member]                
Shares surrendered 289,731